EDGAR ENGLEMAN Insider Profile

4 Followers
EDGAR ENGLEMAN, Director, Ten Percent Owner at Soleno Therapeutics, holds 2.07M shares in Bolt Biotherapeutics (Ticker: BOLT), holds 4.03M shares in Soleno Therapeutics (Ticker: SLNO), holds 1.60M shares in Eiger Biopharmaceuticals (Ticker: EIGRQ). Most recently, EDGAR ENGLEMAN Sold ― shares of Bolt Biotherapeutics on Dec 01, 2023 for an estimated value of 127.84K.
tipranks
EDGAR ENGLEMAN

EDGAR ENGLEMAN
Soleno Therapeutics (SLNO)
Director, Ten Percent Owner

Ranked #71,200 out of 99,218 Corporate Insiders

Profitable Transactions

57%
4 out of 7 Profitable Transactions

Average Return

-11.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$230M
99.42%
0.58%
A breakdown of EDGAR ENGLEMAN's holdings

Insider Roles

Soleno Therapeutics
(SLNO)
Director, Ten Percent Owner
Bolt Biotherapeutics
(BOLT)
Director
Roles that EDGAR ENGLEMAN holds in companies

Most Profitable Insider Trade

Stock:
Bolt Biotherapeutics
(BOLT)
Rating:Informative Sell
Date:Nov 20, 2023 - Today
Return:+28.00%
The most profitable trade made by EDGAR ENGLEMAN

EDGAR ENGLEMAN's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Soleno Therapeutics
Feb 07, 2018
Director, Ten Percent Owner
Uninformative Buy
8.72K
$228.99M
EIGRQ
Eiger Biopharmaceuticals
Mar 25, 2016
Informative Buy
$13.60M
Bolt Biotherapeutics
Dec 01, 2023
Director
Informative Sell
127.84K
$1.34M
List of latest transactions for each holding click on a transaction to see EDGAR ENGLEMAN's performance on stock

EDGAR ENGLEMAN insider profile FAQ

What is the percentage of profitable transactions made by EDGAR ENGLEMAN?
The percentage of profitable transactions made by EDGAR ENGLEMAN is 57%.
    What is the average return per transaction made by EDGAR ENGLEMAN?
    The average return per transaction made by EDGAR ENGLEMAN is -11.20%.
      What stocks does EDGAR ENGLEMAN hold?
      EDGAR ENGLEMAN holds: SLNO, EIGRQ, BOLT stocks.
        What was EDGAR ENGLEMAN’s latest transaction?
        EDGAR ENGLEMAN latest transaction was an Informative Sell of $127.84K.
          What was EDGAR ENGLEMAN's most profitable transaction?
          EDGAR ENGLEMAN’s most profitable transaction was an Informative Sell of BOLT stock on November 20, 2023. The return on the trade was 28.00%.
            What is EDGAR ENGLEMAN's role in Soleno Therapeutics?
            EDGAR ENGLEMAN's role in Soleno Therapeutics is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.